Background illustration for clinical trials search

Paid Clinical Trials Texas

Discover 5,035 paid clinical trials in Texas. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

Contingency Management Plus Deep Transcranial Magnetic Stimulation for the Treatment of Cocaine Use Disorder

for
Cocaine Use Disorder (CUD)
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 18 - 65

Code: NCT07490600

Recruiting
Active & Responsive

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

for
Alzheimer Disease
Location: Watertown MA, Methuen MA, Albany NY, Aventura FL,
Sponsor: Alpha Cognition, Inc

Sex: All

Age: 50+

Code: NCT07633470

Phase 4, Recruiting
Active & Responsive

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

for
Hyperphosphatemia,
Location: Orange CT, Middlebury CT, Ridgewood NY, Norfolk VA,
Sponsor: R1 Therapeutics

Sex: All

Age: 18+

Code: NCT06712654

Phase 2, Recruiting
Active & Responsive

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

for
Advanced Breast Cancer, Early Breast Cancer
Location: Westbury NY, The Bronx NY, New York NY, Amsterdam NY,
Sponsor: TerSera Therapeutics LLC

Sex: Female

Age: 18 - 55

Code: NCT07310420

Phase 1, Recruiting
Active & Responsive

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

for
Solid Tumors
Location: Boston MA, St. Petersburg FL, Germantown TN,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT07415031

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial

for
Myopia
Location: Boston MA, New York NY, Elkins Park PA, Columbus OH,
Sponsor: Ohio State University

Sex: All

Age: 6 - 11

Code: NCT07567040

Phase 3, Recruiting
Active & Responsive

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

for
Primary Myelofibrosis (PMF),
Location: New Haven CT, New York NY, Albany NY,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07357727

Phase 3, Recruiting
Active & Responsive

Phase 2 Study to Assess the Safety and Efficacy of ANG003

for
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Location: Boston MA, New Brunswick NJ, Hershey PA, Akron OH,
Sponsor: Anagram Therapeutics, Inc.

Sex: All

Age: 12+

Code: NCT07450547

Phase 2, Recruiting
Active & Responsive

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

for
Macular Degeneration, Age-Related Macular Degeneration,
Location: Portland ME, Waterford CT, Manchester CT,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 50+

Code: NCT07496567

Phase 2, Phase 3, Recruiting
Active & Responsive

A Culturally Adapted Decision Aid Intervention to Support Chinese American Dementia Caregivers in Feeding-Related Decisions

for
Dementia Caregivers, End of Life Decision Making,
Location: Austin TX
Sponsor: Yaolin Pei

Sex: All

Age: 21 - 70+

Code: NCT07370311

Recruiting
Active & Responsive

Real-World Assessment of VEVYE® for Short-Term Symptom and Sign Improvement of Dry Eye Disease in a Neuro-Ophthalmology Clinic: A 6-Month Prospective Observational Study

for
Dry Eye
Location: Houston TX
Sponsor: Neuro-Ophthalmology of Texas

Sex: All

Age: 18+

Code: NCT07566975

Recruiting
Active & Responsive

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

for
HR+ HER2- Breast Cancer
Location: Nashville TN, Austin TX, San Antonio TX, Lone Tree CO,
Sponsor: Faeth Therapeutics

Sex: All

Age: 18+

Code: NCT07558733

Phase 1, Phase 2, Recruiting
Active & Responsive

A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)

for
Angiokeratomas
Location: Dawsonville GA, Southlake TX
Sponsor: Palvella Therapeutics, Inc.

Sex: All

Age: 6+

Code: NCT07552077

Phase 2, Recruiting
Active & Responsive

A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria

for
Phenylketonuria
Location: Pittsburgh PA, Indianapolis IN, Dallas TX
Sponsor: Agios Pharmaceuticals, Inc.

Sex: All

Age: 18 - 69

Code: NCT07241234

Phase 1, Recruiting
Active & Responsive

A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients

for
High-Risk Neuroblastoma
Location: The Bronx NY, Philadelphia PA, Durham NC, Toronto,
Sponsor: Renaissance Pharma Ltd.

Sex: All

Age: 1 - 18

Code: NCT07549321

Phase 2, Phase 3, Recruiting
Active & Responsive

A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement

for
FGFR2 Gene Fusion/Rearrangement, Other Solid Tumors, Adult
Location: Boston MA, New York NY, Tampa FL, Chicago IL,
Sponsor: Elevar Therapeutics

Sex: All

Age: 18+

Code: NCT07359820

Phase 2, Recruiting
Active & Responsive

A Study of TAK-505 in Adults With Solid Tumors

for
Malignant Solid Tumors
Location: Fairfax VA, Tampa FL, Nashville TN, Minneapolis MN,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT07436728

Phase 1, Phase 2, Recruiting
Active & Responsive

Study of ALK-001 on the Progression of Stargardt Disease

for
Stargardt Disease
Location: Norfolk VA, Fairfax VA, Pittsburgh PA, Erie PA,
Sponsor: Alkeus Pharmaceuticals, Inc.

Sex: All

Age: 8 - 45

Code: NCT07419334

Phase 3, Recruiting
Active & Responsive

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

for
Type 1 Diabetes, New Onset
Location: New Haven CT, Miami FL, Buffalo NY, Pittsburgh PA,
Sponsor: City of Hope Medical Center

Sex: All

Age: 9 - 20

Code: NCT07061574

Phase 1, Phase 2, Recruiting
Active & Responsive

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

for
Primary Sjogren's Disease
Location: Boston MA, Philadelphia PA, Willow Grove PA,
Sponsor: Vor Biopharma

Sex: All

Age: 18 - 70+

Code: NCT07404865

Phase 3, Recruiting

Popular cities in Texas

With a broad healthcare network and leading medical research centers, Texas is a key location for a wide range of clinical trials. Major institutions such as MD Anderson Cancer Center, Baylor College of Medicine, UT Southwestern Medical Center, and Texas Heart Institute are at the forefront of these studies.

Why choose Texas for clinical trials?

Texas offers unique advantages for those participating in clinical trials. The state's diverse population provides a broad range of participants, which enhances the reliability and relevance of research findings. Texas is also known for its innovative research environment, with a strong focus on medical advancements and cutting-edge studies.

By choosing to participate in a clinical trial in Texas, you contribute to important medical research while benefiting from a well-established and supportive clinical research system.

Common conditions studied in Texas

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Texas